Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.
Genetic Analysis Market Growth From $11.62 Billion In 2026 To $18.75 Billion By 2030 At A CAGR Of 12.7%
The genetic analysis market has seen substantial expansion in recent years. Its value is anticipated to rise from $10.29 billion in 2025 to $11.63 billion in 2026, achieving a compound annual growth rate (CAGR) of 13.0%. This historical growth can be attributed to several factors including the restricted access to high-throughput sequencing platforms, a reliance on conventional genetic testing methods, increasing public understanding of genetic disorders, greater investment in research laboratories, and a growing number of diagnostic facilities.
The genetic analysis market size is anticipated to experience substantial growth in the coming years. It is projected to reach $18.75 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 12.7%. This expansion during the forecast period is propelled by advancements in NGS and real-time PCR technologies, the development of cloud-based genomic data platforms, increasing embrace of personalized medicine, rising government initiatives for genetic disease screening, and the integration of AI and bioinformatics tools within diagnostics. Notable trends expected in this period include the broadening of next-generation sequencing (NGS) and PCR-based genetic testing, a growing adoption of pharmacogenomic testing for personalized medicine, an increase in prenatal and newborn genetic screening programs, a heightened focus on rare disease and cancer genetic diagnostics, and the integration of bioinformatics and genomic data analysis tools.
Get A Free Sample Report With In-Depth Market Insights:
Genetic Analysis Market Demand Drivers: What’s Powering Industry Growth?
The genetic analysis market is projected to expand due to the growing incidence of cancer. Cancer is a condition where body cells multiply uncontrollably and can spread to other areas. The rise in cancer cases is linked to an aging demographic, given that elderly individuals are more prone to developing genetic mutations and prolonged exposure to environmental and lifestyle factors associated with cancer. Genetic analysis proves valuable in cancer care by identifying particular genetic mutations causing the illness, enabling physicians to select more effective targeted therapies with reduced side effects. For example, a report from the National Cancer Institute (NCI), a US-based entity focused on cancer research and training, stated in May 2025 that approximately 20 million individuals globally received a new cancer diagnosis in 2022, and around 9.7 million succumbed to the disease. Projections indicate that by 2050, the yearly figure for new cancer diagnoses might reach 33 million, with cancer fatalities anticipated to increase to 18.2 million. Consequently, the escalating number of cancer cases is fueling the expansion of the genetic analysis market.
Genetic Analysis Market Segment Breakdown: Which Categories Lead On Revenue?
The genetic analysis market covered in this report is segmented –
1) By Product: Reagents And Kits, Instruments, Software
2) By Test: Predictive Genetic Testing, Carrier Testing, Prenatal And Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing, Other Tests
3) By Technology: Next-Generation Sequencing (NGS), Real-Time PCR System, Other Technologies
4) By Application: Cancer, Genetic Diseases, Cardiovascular Diseases, Rare Diseases, Infectious Diseases, Other Applications
5) By End-Use: Hospitals, Research And Development Laboratories, Diagnostic Centers, Other End-Uses
Subsegments:
1) By Reagents And Kits: DNA Extraction Kits, RNA Extraction Kits, PCR Reagents, Sequencing Reagents, Library Preparation Kits, Electrophoresis Reagents, Microarray Kits, Genotyping Assay Kits, Target Enrichment Kits, Nucleic Acid Labeling Kits
2) By Instruments: DNA Sequencers, PCR Machines, Microarray Scanners, Electrophoresis Systems, Real-Time PCR Systems, Automated Sample Preparation Systems, Genetic Analyzers, Bioanalyzers, Fragment Analyzers, Next-Generation Sequencing (NGS) Platforms
3) By Software: Data Analysis Software, Bioinformatics Tools, Laboratory Information Management Systems (LIMS), Genomic Data Interpretation Software, DNA Sequence Alignment Tools, Variant Annotation Software, Clinical Decision Support Software, Cloud-Based Genomic Platforms, Workflow Management Software, Data Visualization Tools
Genetic Analysis Market Innovation Trends: What Developments Are Reshaping The Industry?
Leading companies in the genetic analysis market are concentrating on developing advanced solutions, such as genetic testing, to facilitate preventive measures or early monitoring. Genetic testing involves analyzing a person’s DNA to identify changes or variations in genes that might be linked to specific health conditions or inherited traits. For example, in June 2023, Devyser, a Sweden-based company specializing in diagnostic kit development, launched Devyser LynchFAP and Devyser BRCA PALB2, two genetic testing solutions designed for hereditary cancer. Devyser LynchFAP distinguishes itself by offering a complete solution for analyzing PMS2 and nine additional genes associated with hereditary colorectal cancer, effectively resolving the intricate challenge of differentiating PMS2 from its pseudogene PMS2CL. It represents the first commercial kit specifically engineered for the precise analysis of the PMS2 gene. Devyser BRCA PALB2 allows for the targeted detection of genetic variants in BRCA1, BRCA2, and PALB2, which are key genes linked to an increased risk of breast and ovarian cancer. Its user-friendly design enables quick integration into lab workflows and supports the analysis of DNA from both blood and tumor samples within a single test.
Genetic Analysis Market Leading Players And Competitive Positioning
Major companies operating in the genetic analysis market are Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Abbott Laboratories Inc., Danaher Corporation, Quest Diagnostics Inc., Illumina Inc., PerkinElmer Inc., BioRad Laboratories Inc., Qiagen NV, Oxford Nanopore Technologies Plc, 23andMe Inc., ELITech Group, MyHeritage Ltd., Dante Labs Inc., AutoGenomics Inc., IntegraGen SA, Family Tree DNA, 24 genetics, Centrillion Biosciences Inc., DNA Worldwide Group Ltd., Genebase.
View The Full Genetic Analysis Market Report:
Genetic Analysis Market Global Footprint: Which Region Leads The Market?
North America was the largest region in the genetic analysis market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the genetic analysis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model